Poster: Modulation Of Chaperone Gene Expression In Mutagenised S. Cerevisiae Strains Developed For rHA Production Results In Increased Production Of Multiple Heterologous Proteins
Source: Novozymes Biopharma US Inc.
The yeast S. cerevisiae has been successfully established as a commercially viable system for the production of recombinant proteins. A wide range of both industrially and medically important proteins have been produced using this organism, from hormones and antibodies to cytokines and blood proteins. Manipulation of chaperone gene expression has been utilised extensively to increase recombinant protein production from S. cerevisiae, focusing predominantly on the protein disulphide isomerise PDI1 and the hsp70 KAR2.
access the Download!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more